In addition, ASF1B expression in different molecular subtypes of ACC, BRCA, COAD, Esophageal carcinoma (ESCA), Glioblastoma multiforme (GBM), Head and Neck squamous cell carcinoma (HNSC), KIRP, Brain Lower Grade Glioma (LGG), LUSC, Ovarian serous cystadenocarcinoma (OV), Prostate adenocarcinoma (PRAD), Rectum adenocarcinoma (READ), SKCM, Stomach adenocarcinoma (STAD), Uterine Corpus Endometrial Carcinoma (UCEC) was significantly different (Figure 1D). This evidence concerns the gene ASF1B and ovarian serous cystadenocarcinoma.